| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | PFIZER INC. CMN | Jun 16, 2026 | |
| Sell | Pfizer, Inc. Common Stock | Jun 8, 2026 | |
| Sell | PFIZER INC. CMN | Jun 2, 2026 | |
| Buy | PFIZER INC. CMN | May 27, 2026 | |
| Sell | PFIZER INC | May 11, 2026 | |
| Buy | PFIZER INC. CMN | May 6, 2026 | |
| Buy | FIFTH THIRD BANCORP CMN | Apr 30, 2026 | |
| Buy | PFIZER INC. CMN | Apr 26, 2026 | |
| Buy | PFIZER INTERNATIONAL FINANCI | Apr 24, 2026 | |
| Buy | PFIZER INC CMN | Apr 24, 2026 |
This page tracks congressional stock trading activity in Pfizer Inc. (PFE) in the Healthcare sector. Disclosed Capitol has indexed 618 disclosed congressional trades involving PFE. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of August 2026 — Disclosed Capitol has tracked 618 disclosed congressional trades in Pfizer Inc. (PFE) — 301:194 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Jun 16, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Jun 8, 2026 | Thomas H Tuberville | R | Sell | $15,001 - $50,000 |
| Jun 2, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| May 27, 2026 | Diana Harshbarger | R | Buy | $15,001 - $50,000 |
| May 11, 2026 | Michael McCaul | R | Sell | $1,001 - $15,000 |
| May 6, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Apr 30, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Apr 26, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Apr 24, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Apr 24, 2026 | Ro Khanna | D | Buy | $50,001 - $100,000 |
Across the 618 disclosed congressional trades in Pfizer Inc. (PFE), members of Congress have reported 194 buys and 301 sells. The average 30-day alpha vs. the S&P 500 is -0.61%.
As of June 2026, Pfizer Inc. has 239 federal contract award records on file from USAspending.gov — most recently $359K from the Department of Health and Human Services on 2026-06-08.
| Award date | Agency | Amount |
|---|---|---|
| 2026-06-08 | Department of Health and Human Services · Centers for Disease Control and Prevention | $359K |
| 2026-06-08 | Department of Health and Human Services · Centers for Disease Control and Prevention | $284.3M |
| 2026-05-29 | Department of Health and Human Services · Centers for Disease Control and Prevention | $381K |
| 2026-05-29 | Department of Health and Human Services · Centers for Disease Control and Prevention | $4.6M |
| 2026-05-15 | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | $543K |
| 2026-05-12 | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | -$1.4M |
| 2026-05-08 | Department of Health and Human Services · Centers for Disease Control and Prevention | $410K |
| 2026-03-27 | Department of Health and Human Services · Centers for Disease Control and Prevention | $187.6M |
| 2026-03-13 | Department of Health and Human Services · Centers for Disease Control and Prevention | $1.3M |
| 2026-03-05 | Department of Health and Human Services · Centers for Disease Control and Prevention | $133K |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, Pfizer Inc. reported revenue of $63.63B and net income of $8.03B, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $15.03B, net income -$247.0M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.